X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Tech Mahindra partners StaTwig for blockchain-based traceability solution for vaccine supply chain

Content Team by Content Team
9th July 2021
in News
Tech Mahindra partners StaTwig for blockchain-based traceability solution for vaccine supply chain

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

IT major Tech Mahindra said it has partnered with StaTwig, a Singapore and Hyderabad-based digital supply chain solution provider, to implement vaccine traceability platform “VaccineLedger” globally.

The companies aim to roll-out a blockchain-based traceability solution for global vaccine supply chain transparency, predict and prevent failures in supply chains, including problems related to expired vaccines, stock out and counterfeiting, a statement said.

VaccineLedger is an open source platform and designed to perform end-to-end traceability at vial level for vaccines in the global supply chain. It prevents the need of replacing the existing system, therefore, removing the barriers of adoption.

It can easily integrate with existing systems and show immediate results in the countries where it is deployed.

Through this partnership, Tech Mahindra and StaTwig will work towards building a global consortium of vaccine researchers, governments, pharmaceutical companies, distributors, and healthcare workers, the statement said.

  • BSE acted as catalyst in helping India create $3 trillion in wealth: Ashishkumar Chauhan
  • Gold loan defaults rise after COVID-19 second wave, drop in prices
  • Offer education in Indian languages, Centre tells technical institutes

StaTwig will leverage Tech Mahindra’s go-to-market expertise, including access to sales and customer network, domain experience, balance sheet support, resource scale and system integration knowledge.

Further, Tech Mahindra has also invested in co-development and testing of various enterprise security modules for the mobile and web application, to support the unique requirements from manufacturers and state governments.

“Wastage of life saving drugs such as vaccines should be addressed on priority and we need to come together in order to effectively find a solution here.

“Our strategic partnership with StaTwig will enable supply chain participants with a single application to enhance traceability, and chain of custody,” Tech Mahindra Blockchain and Cybersecurity Practice Leader – APAC and EMEA Rajesh Dhuddu said.

This will not only ensure safety and validity of vaccine supply but also helps in adherence to complex regulatory requirements, set up by Drug Administration Authority in any country, he added.

A blockchain-based application builds peer to peer bridges on current systems that support real time data sharing, authentication and validation. Vaccine manufacturers can use such data beyond track and trace to inventory management, vendor payments, IoT integration and smart contract.

“With VaccineLedger, we are aiming to re-design and re-engineer the traditional supply chain information systems to give continuous visibility and complete traceability.

“With the help of VaccineLedger, vaccine manufacturers and governments can work together to prevent counterfeiting, cold-chain failures and stock outs,” Sid Chakravarthy, Founder and CEO of StaTwig, said.

StaTwig is a UNICEF Innovation Fund Portfolio startup and the World Economic Forum Global Innovator focused on solving supply chain failures in multiple critical industries such as vaccines and food with easy to use apps that leverage its highly scalable and secure blockchain based supply chain management platform.

Previous Post

CluePoints Launch Post-COVID Trial Assurance Solution

Next Post

Turkish Cargo Carried 100 million Vaccine Doses to All Around the World

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post
Turkish Cargo Carried 100 million Vaccine Doses to All Around the World

Turkish Cargo Carried 100 million Vaccine Doses to All Around the World

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In